SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001626199-20-000011
Filing Date
2020-03-30
Accepted
2020-03-30 16:42:20
Documents
4
Effectiveness Date
2020-03-30

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_20200330xevergreen.htm S-8 138777
2 EXHIBIT 5.1 alpn-ex51_20200330.htm EX-5.1 9064
3 EXHIBIT 23.1 alpn-ex231_20200330.htm EX-23.1 3626
4 alpnex5120200330image1.gif GRAPHIC 3199
  Complete submission text file 0001626199-20-000011.txt   157215
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237479 | Film No.: 20757718
SIC: 2834 Pharmaceutical Preparations